Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation

Published:2018-07-19 Issue:1 Volume:98 Page:237-240
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Kim Tae Kon^ORCID,DeVeaux Michelle,Stahl Maximilian,Perreault Sarah,Isufi Iris,Cooper Dennis,Foss Francine,Shlomchik Warren,Zelterman Daniel,Zeidan Amer M.,Seropian Stuart

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-018-3427-1/fulltext.html

Reference21 articles.

1. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR, Storb R, McDonald GB (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363(22):2091–2101. https://doi.org/10.1056/NEJMoa1004383

2. Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD, Maziarz RT, Cortes J, Kalaycio ME, Horowitz MM (2013) Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). Blood 122(11):1974–1982. https://doi.org/10.1182/blood-2013-04-496778

3. Saber W, Opie S, Rizzo JD, Zhang MJ, Horowitz MM, Schriber J (2012) Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood 119(17):3908–3916. https://doi.org/10.1182/blood-2011-09-381699

4. Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T et al (2014) Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT. Bone Marrow Transplant 49(9):1187–1192. https://doi.org/10.1038/bmt.2014.141

5. Ho VT, Kim HT, Liney D, Milford E, Gribben J, Cutler C, Lee SJ, Antin JH, Soiffer RJ, Alyea EP (2006) HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant 37(9):845–850. https://doi.org/10.1038/sj.bmt.1705315

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation;Annals of Hematology;2020-05-07

2. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial;The Lancet Haematology;2019-08